Touchlight and Odimma Therapeutics Announce Clinical Material Supply Agreement to Develop…
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, announces a development and supply agreement with Odimma Therapeutics, a French…
Read More...
Read More...
